Andrew Brenner

The University of Texas at San Antonio Health Science Center

Also affiliated with Mays Cancer Center at UT Health San Antonio, The University of Texas at San Antonio

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours”.

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

British Journal of Cancer(2020)10.1038/s41416-020-0802-1

N/A

3.4DataRank · unranked

924 citations

Yoon‐Koo Kang, Mitesh J. Borad, Jasgit C. Sachdev, Samuel Ejadi, Ho Yeong Lim +18 more

Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0117

N/A

0.603DataRank · unranked

12 citations

William J. Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew Brenner, Alison Stopeck +8 more

Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae186

N/A

0.574DataRank · unranked

17 citations

Andrew Brenner, David Piccioni, Patrick Y Wen, Jan Drappatz, Maciej Mrugala +10 more

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Breast Cancer Research(2023)10.1186/s13058-023-01727-z

N/A

0.405DataRank · unranked

7 citations

Larry E. Broome, Kate Lathrop, Ismail Jatoi, Andrew Brenner, Alia Nazarullah +6 more

Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0031

N/A

0.388DataRank · unranked

6 citations

Michael Tidwell, Henriette U. Balinda, Nicholas A. Clanton, Xue Yang, Suryavathi Viswanadhapalli +10 more

Image-guided patient-specific optimization of catheter placement for convection-enhanced nanoparticle delivery in recurrent glioblastoma

Computers in Biology and Medicine(2024)10.1016/j.compbiomed.2024.108889

N/A

0.361DataRank · unranked

7 citations

David A. Hormuth, Chase Christenson, Ryan T. Woodall, Michael Abdelmalik, William T. Phillips +4 more

Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U

JCO Precision Oncology(2024)10.1200/po.24.00327

N/A

0.260DataRank · unranked

4 citations

Opeyemi A. Jegede, David M. Jackman, James A. Zwiebel, Robert J. Gray, Victoria Wang +17 more

Theoretical virtues and the methodological analogy between science and metaphysics

Synthese(2023)10.1007/s11229-023-04047-z

N/A

0.241DataRank · unranked

4 citations

Andrew Brenner

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events

Cancer Letters(2022)10.1016/j.canlet.2022.215717

N/A

0DataRank · unranked

36 citations

Subapriya Rajamanickam, Arhan Rao, Panneerdoss Subbarayalu, Saif Nirzhor, Nourhan Abdelfattah +8 more

ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics

Neuro-Oncology(2022)10.1093/neuonc/noac179

N/A

0DataRank · unranked

21 citations

Jennifer Chiou, Gabriela D. A. Guardia, Xiufen Lei, Henriette Balinda, Tesha Landry +8 more

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide

Frontiers in Oncology(2022)10.3389/fonc.2022.900082

N/A

0DataRank · unranked

10 citations

Renu Pandey, Jennifer Chiou, Ayon Bhattacharya, Shi‐Liang Huang, Xingxin Pan +5 more

Targeting aberrant replication and DNA repair events for treating breast cancers

Communications Biology(2022)10.1038/s42003-022-03413-w

N/A

0DataRank · unranked

8 citations

Jun Hyoung Park, Panneerdoss Subbarayalu, Santosh Timilsina, Kaitlyn Bates, Pooja Yadav +20 more

Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2807

N/A

0DataRank · unranked

122 citations

Adolfo Enrique Diaz Duque, Joel Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen +5 more

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

Neuro-Oncology(2023)10.1093/neuonc/noad018

N/A

0DataRank · unranked

51 citations

Bridgitte E. Palacios, Prabhakar Pitta Venkata, Yi He, Wenjing Li, Jessica D. Johnson +20 more

AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages

Cell Reports(2023)10.1016/j.celrep.2023.113067

N/A

0DataRank · unranked

22 citations

Meizhen Chen, Daniel T. DeArmond, Cheryl Hsiang-Ling Chiu, Catherine A. Limboy, Xi Tan +19 more

Inhibition of FASN as a potential treatment of advanced endocrine therapy-resistant breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13077

N/A

0DataRank · unranked

3 citations

Henriette Balinda, Andrew Brenner, Avani Gunuganti

H/ACA snoRNAs and snoRNPs Dysregulation Links rRNA Modification to Glioblastoma Progression

Research Square(2025)10.21203/rs.3.rs-8079210/v1

N/A

0DataRank · unranked

0 citations

Xiufen Lei, Christina Middle, Morgan Roos, Lea Damaschke, Sreenevash Ramesh +12 more

The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation

Genome biology(2020)10.1186/s13059-020-02115-y

N/A

0DataRank · unranked

127 citations

Patricia Rosa De Araujo, Wei-Qing Li, Gabriela D. A. Guardia, Jennifer Chiou, Caihong Yi +26 more

KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05963-1

N/A

0DataRank · unranked

49 citations

Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, Bridgitte E. Palacios, Salvador Alejo, Yihong Chen +11 more

Primary CNS lymphoma commonly expresses immune response biomarkers

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa018

N/A

0DataRank · unranked

36 citations

Ashley Sumrall, Surasak Phuphanich, David Spetzler, Zoran Gatalica, Joanne Xiu +9 more

Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0446

N/A

0DataRank · unranked

39 citations

John H. Sampson, Achal S. Achrol, Manish K. Aghi, Krystof Bankiewicz, Chencai Wang +16 more

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Communications Biology(2021)10.1038/s42003-021-02741-7

N/A

0DataRank · unranked

23 citations

Suryavathi Viswanadhapalli, Bindu Santhamma, Uday P. Pratap, Yiliao Luo, Junhao Liu +21 more

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab099

N/A

0DataRank · unranked

18 citations

Gangadhara R. Sareddy, Zexuan Liu, Prabhakar Pitta Venkata, Junhao Liu, Weiwei Tang +9 more

Safety and feasibility of rhenium-186 nanoliposome (186RNL) in recurrent glioma: The ReSPECT phase 1 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2061

N/A

0DataRank · unranked

9 citations

Ande Bao, William T. Phillips, Gregory Stein, Vibhudutta Awasthi, Toral Patel +3 more